More than 50 per cent of Chinese men smoke cigarettes, placing hundreds of millions at serious risk for heart disease, cancer, other lung diseases, and many more serious illnesses, according to the American Cancer Society ...
Dec 11, 2013
Indulgences abound during the holidays—from family gatherings to parties with friends and even stockings stuffed with goodies from Santa. For children with diabetes, overindulging on the delicacies of the season could result ...
Dec 11, 2013
For the first time, large-scale information on the biochemical makeup of small interfering RNA (siRNA) molecules is available publicly. These molecules are used in research to help scientists better understand how genes function ...
Dec 11, 2013
An article published in the journal Nutricion Hospitalaria reveals that the attitude of healthcare personnel, along with starting early breast-feeding, are another two factors that help in increasing the mothers' level of ...
Dec 11, 2013
A prison sentence may not always have negative consequences for children of the incarcerated, says University of California, Irvine sociologist Kristin Turney. In a new study, she finds that when an uninvolved dad spends ...
Dec 11, 2013
Chinese researchers from Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, BGI and other institutes identified the recurrent T372R mutation in the transcription factor YY1 (Yin Yang 1) are related with insulinoma ...
Dec 11, 2013
First, the number of chromosomes in a cell changes, then an avalanche of further mutations occur that transform the cell into a cancer cell, according to a well-known - but untested - theory. A research group at Lund University ...
Dec 11, 2013
Combining the chemotherapy drugs docetaxel and carboplatin with the HER2-targeted therapy trastuzumab was identified to be an ideal postsurgery treatment option for patients with HER2-positive breast cancer, regardless of ...
Dec 11, 2013
Results from the initial analysis of event-free and overall survival for patients enrolled in the randomized, phase III Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimization (NeoALTTO) trial are to be presented ...
Dec 11, 2013
Women with HER2-positive breast cancer who had the highest levels of immune cells in their tumors gained the most benefit from presurgery treatment with chemotherapy and trastuzumab, according to results presented here at ...
Dec 11, 2013
